Global Point of Care Diagnostics Market 2016 Share, Trend, Segmentation and Forecast to 2022
According to researcher, the Global Point of Care Diagnostics Market is expected to grow at a CAGR of 9.7 % to reach $32.7 billion by 2022. The speed factor, particularly, is the utmost strength of PoC diagnostics as quicker diagnosis facilitates sooner patient management. Increasing incidence of chronic disorders and contagious diseases, that need portable and quick diagnosis, is estimated to fuel the market growth. Lack of co-ordination among healthcare centers, practitioners, and manufacturers is the major factor hindering the point of care diagnostics market.
Complete report details @ https://www.wiseguyreports.com/reports/point-of-care-diagnostics-global-market-outlook-2015-2022
Recently, the blood testing segment has been a major contributor to the market, strongly driven by portable glucose monitoring devices. Transmittable diseases, including HIV/AIDS, TB, and hepatitis, will be a rising hub for POC moving ahead. In 2015, North America commanded the POC diagnostics market accounting for more than 40% of the global revenue. Asia Pacific is projected to grow at a productive rate due to the presence of high unmet medical requirements, increase in disposable income and enhancement in healthcare infrastructure in emerging economies. In future, countries such as Japan, China, India, Brazil and Mexico are projected to grow as hot spots for progress of POCT technology.
The key players in global Point of Care Diagnostics market are Roche Diagnostics Limited, Abbott Laboratories, Inc., Johnson & Johnson, Becton, Dickinson And Company, Siemens Healthcare, Bayer Healthcare AG, Nova Biomedical, Abaxis, Inc., Pharmatech Inc., Nipro Diagnostics Inc, Beckman Coulter Inc, BioMérieux, Alere Inc., Danaher Corporation and Spectral Diagnostics.
Request a free sample report @ https://www.wiseguyreports.com/sample-request/point-of-care-diagnostics-global-market-outlook-2015-2022
Technologies Covered:
• Rapid HIV Tests
• Electrodes
• Biosensors
• Continuous Testing
• Drug Testing
• Others
End Users Covered:
• Assisted Living Healthcare Facilities
• Clinics
• Home
• Hospitals
• Laboratories
• Others
Types of Prescription Covered:
• OTC Testing Kits
• Prescription-Based Testing Kits
Products Covered:
• Infectious Diseases Testing Kits
o Hepatitis Testing Kits
o Tropical Diseases Testing Kits
o Influenza Testing Kits
o Sexually-Transmitted Diseases (Stds) Testing Kits
o HIV Testing Kits
o Tuberculosis (TB) Testing Kits
• Pregnancy and Fertility Testing Kits
o Fertility Testing Kits
o Pregnancy Testing Kits
• Glucose Monitoring Kits
o Glucose Monitoring Devices
o Glucose Monitoring Strips
o Lancets
• Coagulation Monitoring Kits
o Activated Clotting Time (Act/Aptt) Testing Kits
o Prothrombin Time (Pt/Inr) Testing Kits
• Hematology Testing Kits
o Hemostasis Assay Kits
o Hemoglobin Assay Kits
• Blood Gas/Electrolytes Testing Kits
• Cardiac Markers
• Cholesterol Test Strips
• Fecal Occult Testing Kits
• Food Pathogens Testing Kits
• Tumor/Cancer Markers
• Urinalysis Testing Kits
• Others
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/point-of-care-diagnostics-global-market-outlook-2015-2022
Table of content
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 End User Analysis
3.9 Emerging markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Point of Care Diagnostics Market, By Technology
5.1 Introduction
5.2 Rapid HIV Tests
5.3 Electrodes
5.4 Biosensors
5.6 Continuous Testing
5.7 Drug Testing
5.8 Others
6 Global Point of Care Diagnostics Market, By End User
6.1 Introduction
6.2 Assisted Living Healthcare Facilities
6.3 Clinics
6.4 Home
6.5 Hospitals
6.6 Laboratories
6.7 Others
7 Global Point of Care Diagnostics Market, By Type of Prescription
7.1 Introduction
7.2 OTC Testing Kits
7.3 Prescription-Based Testing Kits
8 Global Point of Care Diagnostics Market, By Product
8.1 Infectious Diseases Testing Kits
8.1.1 Hepatitis Testing Kits
8.1.2 Tropical Diseases Testing Kits
8.1.3 Influenza Testing Kits
8.1.4 Sexually-Transmitted Diseases (Stds) Testing Kits
8.1.5 HIV Testing Kits
8.1.6 Tuberculosis (TB) Testing Kits
8.2 Pregnancy and Fertility Testing Kits
8.2.1 Fertility Testing Kits
8.2.2 Pregnancy Testing Kits
8.3 Glucose Monitoring Kits
8.3.1 Glucose Monitoring Devices
8.3.2 Glucose Monitoring Strips
8.3.3 Lancets
8.4 Coagulation Monitoring Kits
8.4.1 Activated Clotting Time (Act/Aptt) Testing Kits
8.4.2 Prothrombin Time (Pt/Inr) Testing Kits
8.5 Hematology Testing Kits
8.5.1 Hemostasis Assay Kits
8.5.2 Hemoglobin Assay Kits
8.6 Blood Gas/Electrolytes Testing Kits
8.7 Cardiac Markers
8.8 Cholesterol Test Strips
8.9 Fecal Occult Testing Kits
8.10 Food Pathogens Testing Kits
8.11 Tumor/Cancer Markers
8.12 Urinalysis Testing Kits
8.13 Others
9 Global Point of Care Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics Limited
11.2 Abbott Laboratories, Inc.
11.3 Johnson & Johnson
11.4 Becton, Dickinson And Company
11.5 Siemens Healthcare
11.6 Bayer Healthcare Ag
11.7 Nova Biomedical
11.8 Abaxis, Inc.
11.9 Pharmatech Inc.
11.10 Nipro Diagnostics Inc.
11.11 Beckman Coulter Inc
11.12 BioMérieux
11.13 Alere Inc.
11.14 Danaher Corporation
11.15 Spectral Diagnostics
Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=339149
Contact US:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Thursday August 11 2016, 4:05 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
